Bank of New York Mellon’s Krystal Biotech KRYS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$22.1M Sell
160,517
-8,662
-5% -$1.19M ﹤0.01% 1466
2025
Q1
$30.5M Sell
169,179
-167
-0.1% -$30.1K 0.01% 1266
2024
Q4
$26.5M Sell
169,346
-2,307
-1% -$361K ﹤0.01% 1393
2024
Q3
$31.2M Sell
171,653
-22,114
-11% -$4.03M 0.01% 1314
2024
Q2
$35.6M Buy
193,767
+103,928
+116% +$19.1M 0.01% 1229
2024
Q1
$16M Sell
89,839
-8,812
-9% -$1.57M ﹤0.01% 1704
2023
Q4
$12.2M Buy
98,651
+431
+0.4% +$53.5K ﹤0.01% 1866
2023
Q3
$11.4M Buy
98,220
+1,604
+2% +$186K ﹤0.01% 1870
2023
Q2
$11.3M Buy
96,616
+17,053
+21% +$2M ﹤0.01% 1883
2023
Q1
$6.37M Sell
79,563
-2,533
-3% -$203K ﹤0.01% 2164
2022
Q4
$6.5M Sell
82,096
-2,696
-3% -$214K ﹤0.01% 2180
2022
Q3
$5.91M Buy
84,792
+4,529
+6% +$316K ﹤0.01% 2205
2022
Q2
$5.27M Sell
80,263
-6,632
-8% -$435K ﹤0.01% 2265
2022
Q1
$5.78M Buy
86,895
+3,444
+4% +$229K ﹤0.01% 2340
2021
Q4
$5.84M Buy
83,451
+7,022
+9% +$491K ﹤0.01% 2379
2021
Q3
$3.99M Buy
76,429
+5,799
+8% +$303K ﹤0.01% 2593
2021
Q2
$4.8M Buy
70,630
+3,262
+5% +$222K ﹤0.01% 2514
2021
Q1
$5.19M Sell
67,368
-112
-0.2% -$8.63K ﹤0.01% 2436
2020
Q4
$4.05M Buy
67,480
+5,065
+8% +$304K ﹤0.01% 2454
2020
Q3
$2.69M Buy
62,415
+3,502
+6% +$151K ﹤0.01% 2510
2020
Q2
$2.44M Sell
58,913
-6,307
-10% -$261K ﹤0.01% 2561
2020
Q1
$2.82M Sell
65,220
-2,369
-4% -$102K ﹤0.01% 2362
2019
Q4
$3.74M Sell
67,589
-5,027
-7% -$278K ﹤0.01% 2483
2019
Q3
$2.52M Buy
72,616
+7,890
+12% +$274K ﹤0.01% 2630
2019
Q2
$2.61M Buy
64,726
+43,859
+210% +$1.77M ﹤0.01% 2663
2019
Q1
$687K Sell
20,867
-3,810
-15% -$125K ﹤0.01% 3394
2018
Q4
$513K Buy
+24,677
New +$513K ﹤0.01% 3463